For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)
Por um escritor misterioso
Descrição
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.
Drugs Archives - Alzheimer's & Dementia Weekly
Targets, trials and tribulations in Alzheimer therapeutics
New approaches to symptomatic treatments for Alzheimer's disease
REXULTI® (brexpiprazole), MDD
Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation
JAMA Neurology Publishes Complete Results of Positive Phase 3
Rexulti Full Prescribing Information, Dosage & Side Effects
FDA OKs First Drug for Agitation in Alzheimer's Dementia
Brexpiprazole (Rexulti): Uses, Side Effects, Warnings & More - GoodRx
First FDA Approved Medication for Agitation Associated with
